Who to call at ChronicleBio, and when
Fundz watches for the moments ChronicleBio starts buying, and tells you who to reach.
- An alert the day ChronicleBio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ChronicleBio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ChronicleBio. With Fundz connected, it knows.
ChronicleBio and Prolong Pharmaceuticals Form Partnership to Develop PP-007 for Chronic Fatigue Syndrome Treatment.
Contract Type
partnership
Menlo ParkBiotechnologyHealth CareArtificial IntelligenceDescription
ChronicleBio and Prolong Pharmaceuticals have announced a partnership to evaluate PP-007 as a potential treatment for myalgic encephalomyelitis/chronic fatigue syndrome. The Phase 2a trial will assess the drug's effectiveness in improving recovery from post-exertional malaise.
Quick answer
ChronicleBio and Prolong Pharmaceuticals Form Partnership to Develop PP-007 for Chronic Fatigue Syndrome Treatment. (November 12, 2026). ChronicleBio is based in Menlo Park, California, United States.
- What agreement did ChronicleBio announce on November 12, 2026?
- ChronicleBio and Prolong Pharmaceuticals have announced a partnership to evaluate PP-007 as a potential treatment for myalgic encephalomyelitis/chronic fatigue syndrome. The Phase 2a trial will assess the drug's effectiveness in improving recovery from post-exertional malaise.
- What does ChronicleBio do?
- ChronicleBio is a data-driven techbio company utilizing advances in multi-omics and artificial intelligence.
- Where is ChronicleBio based?
- ChronicleBio is based in Menlo Park, California, United States.
- Which similar companies announced agreements around the same time?
- Hologen (November 9, 2026), Prognica Labs (October 22, 2026), Neuratia Labs (October 21, 2026) and Quantum Cyber N.V. (November 12, 2026) also announced agreements within 45 days of ChronicleBio.
Source: Fundz verified event record.
Other recent agreements in Biotechnology and Health Care
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- Hologen and Sysmex Launch Saibogen, a Joint Venture to Enhance Blood Test Insights with AI. (November 9, 2026)
- Prognica Labs and Pinnacology Research & Development Form Partnership to Develop Intranasal Anxiety Therapy (October 22, 2026)
- Neuratia Labs forms strategic partnership with CliniDataCue to bolster healthcare AI and Neuroscience Research. (October 21, 2026)
- Quantum Cyber N.V. Enters into Expanded Intellectual Property License Agreement with LightShift (November 12, 2026)
- Dyadic Applied BioSolutions, BRIG BIO, and Strive Nutrition Form Strategic Collaboration to Advance Alpha-Lactalbumin Production for Premium Nutrition. (November 10, 2026)
- Ocugen Enters Exclusive License Agreement with Celairis Therapeutics (November 10, 2026)
Related People
Agreement Insights
What this usually meansChronicleBio signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.